Company intelligence / Profile preview

Co-High Investment Management

Central, Hong Kong

Ownership: Private
Development stage: Other

Overview

Co-High Investment Management appears to be a financial services and asset management firm rather than a biotechnology, pharmaceutical, or healthcare operating company. Publicly accessible directory and business-profile sources identify it as an investment management entity with operations associated with Hong Kong and China. The available evidence does not indicate that the company develops therapeutics, diagnostics, medical devices, or healthcare services. It may have investment exposure to healthcare or life sciences companies, but it is not itself a life sciences issuer based on the information found.

Industry: Investors

Beyond the preview

Go deeper on Co-High Investment Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Co-High Investment Management.

Explore the full profile